Skip to content
2000
Volume 22, Issue 7
  • ISSN: 0929-8665
  • E-ISSN: 1875-5305

Abstract

UDP-glucose dehydrogenases (EC 1.1.1.22) are responsible for the conversion of UDP-glucose to UDP-glucuronic acid, a key precursor in the biosynthesis of glycoconjugates. Herein we report the discovery and characterization of a UDPglucose dehydrogenase (GbUGD) from Granulibacter bethesdensis, a bacterium originally isolated from the lymph nodes of patients with chronic granulomatous disease (CGD). The recombinant form of the protein was expressed in high yield and the purified enzyme showed highest activity at 37°C/pH 9.0 and was strongly inhibited by Zn2+ ions, sodium dodecyl sulfate (SDS) and urea. UDP-xylose, an allosteric feedback inhibitor, reduced significantly the activity of the enzyme. High activities were observed using the co-substrates UDP-glucose and NAD+, whereas no activity could be detected using other nucleotide sugars or NADP+ as potential alternative substrates. The high activity combined with the simple purification procedure used make GbUGD a valuable new alternative biocatalyst for the synthesis of UDP-glucuronic acid or the development of NAD+ regeneration systems.

Loading

Article metrics loading...

/content/journals/ppl/10.2174/0929866522666150526092818
2015-07-01
2025-06-19
Loading full text...

Full text loading...

/content/journals/ppl/10.2174/0929866522666150526092818
Loading

  • Article Type:
    Research Article
Keyword(s): Granulibacter bethesdensis; UDP-glucose dehydrogenase; UDP-glucuronic acid
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test